当前位置:首页 > 报告详情

安大略省临床试验领导层的雄心勃勃的愿景.pdf

上传人: le****ng 编号:616583 2025-03-07 12页 2.06MB

1、AdvancingClinical Trialsin Ontario Updates from Clinical Trials OntariosOntario Leadership Table for Clinical TrialsDr.Brad WoutersChair,Ontario Leadership Table for Clinical Trials,CTOExecutive Vice President,Science&Research,UHNOntario is a powerhouse in health research19of Canadas Top 40 Research

2、 Hospitals2,200Biotech,medical device,and digital health companies22,000Highly-skilled researchers and staff$1.73 BInvestment in health research56,000Jobs in medical devices,drugs,and pharmaceuticals1,900+4,600Active clinical trials2 more per capita than US$466 MIndustry investment in trialsActive c

3、linical trials63,200+Publications in 20182022(18%in Top Ten Percent)1+14University+Affiliated Hospitals#1Life sciences research hub in Canada#2Number of clinical trials among North American HubsThe OpportunityOntario and Canada as a destination for life sciences and clinical trials innovation5,000+E

4、nrolments in 2023(3,970 thus far in 2024)800+Active interventional trials(53%supported by industry)290+New trials activated annually1,000+Highly-qualified personnel supporting trialsMembershipOntarios top research-intensive hospitalsCanadas leading pharmaceutical companiesGovernment EngagementMinist

5、ry of Colleges and UniversitiesMinistry of Economic Development,Job Creation and TradeMinistry of HealthOntario Leadership Table for Clinical Trials Driving transformational change in clinical trial conductTimely Access to Trials TOP PRIORITYReduce trial start-up time to 45 days RecruitmentDecentral

6、ize recruitment and enable pathways for patient activationHealth Data AccessLeverage data platforms to facilitate research and decision-makingRare DiseaseCapitalize on federal governments new rare disease strategy;improve access to therapies and clinical trials in rare diseaseCollaborative AdvocacyI

word格式文档无特别注明外均可编辑修改,预览文件经过压缩,下载原文更清晰!
三个皮匠报告文库所有资源均是客户上传分享,仅供网友学习交流,未经上传用户书面授权,请勿作商用。
本文主要介绍了加拿大安大略省在临床试验领域的发展和创新。安大略省拥有19所加拿大顶级研究医院,2200家生物科技、医疗设备和数字健康公司,以及22000名高技能研究人员和工作人员。该省在健康研究方面的投资达到17.3亿加元,创造了56000个与医疗设备、药物和数字健康公司相关的就业岗位。安大略省有超过4600项活跃的临床试验,是北美 Hub 中临床 trials 数量第二多的地区。 关键点如下: 1. 安大略省是加拿大生命科学和临床试验创新的重要目的地。 2. 该省致力于将临床试验启动时间缩短至45天,并已开发出通用临床试验协议(UACT)以简化合同流程。 3. 安大略省的生命科学战略包括支持生物制造和生命科学枢纽,新增1.46亿加元投资,其中包括500万加元用于支持临床试验 Ontario QuickSTART 项目。 4. QuickSTART 项目通过标准化流程支持临床试验的快速启动,并正在经历更新以进一步提升效率。 5. 安大略省还计划在其他关键领域进行工作,如招募、健康数据访问、罕见病治疗和合作游说,以进一步推动临床试验生态系统的发展。
" Ontario如何成为临床试验创新领导者?" "加拿大为何选择在安大略省投资生命科学和临床试验?" "安大略省如何通过新协议加速临床试验进程?"
客服
商务合作
小程序
服务号
折叠